Monogram Technologies' Application for mBos TKA System Placed on Hold by FDA
MT Newswires Live10-03
Monogram Technologies (MGRM) said Wednesday the US Food and Drug Administration has placed its 510(k) premarket filing submission for the mBos TKA System on hold pending an additional information request on the robotic surgical system.
The company said it has 180 days from Sept. 30 to provide a complete response to the request or the FDA will consider its application withdrawn. Monogram Technologies is working on the response.
In a separate statement, Monogram said it closed its continuous offering of 8% series D cumulative preferred stock, raising about $13 million in gross proceeds to be used for general working capital.
Price: 2.4399, Change: -0.02, Percent Change: -0.82
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
